The treatment outcome of chronic HBV infection among HBV/HIV co-infected and HBV mono-infected patients

Int J STD AIDS. 2020 Jan;31(1):38-45. doi: 10.1177/0956462419879843. Epub 2019 Dec 15.

Authors

Uroš Karić¹, Ivana Milošević¹, Ivana Pešić-Pavlović², Dubravka Salemović¹, Milan Stojković¹, Djordje Jevtović¹

Affiliations

¹ Hospital for Infectious and Tropical Diseases, Belgrade University School of Medicine, Belgrade, Serbia.
² Department of Microbiology, Clinical Centre of Serbia, Belgrade, Serbia.

PMID: 31838949
DOI: 10.1177/0956462419879843

No abstract available

Keywords: Human immunodeficiency virus; antiretroviral therapy; antiviral; hepatitis B; treatment.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adult
Anti-HIV Agents / therapeutic use
Antiretroviral Therapy, Highly Active*
Antiviral Agents / therapeutic use*
CD4 Lymphocyte Count
Cohort Studies
Coinfection / drug therapy*
Coinfection / epidemiology
Coinfection / virology
Female
HIV Infections / complications
HIV Infections / drug therapy*
HIV Infections / epidemiology
Hepatitis B Surface Antigens / blood
Hepatitis B Surface Antigens / genetics*
Hepatitis B virus / drug effects*
Hepatitis B virus / genetics
Hepatitis B virus / isolation & purification
Hepatitis B, Chronic / drug therapy*
Hepatitis B, Chronic / epidemiology
Humans
Male
Middle Aged
Retrospective Studies
Treatment Outcome

Substances

Anti-HIV Agents
Antiviral Agents
Hepatitis B Surface Antigens